Table 4.
Prevalence | Resistance proportion | |||
---|---|---|---|---|
β | 95% CI | β | 95% CI | |
Study year | 0.008 | −0.001, 0.017 | 0.001 | −0.007, 0.009 |
Age groupa | ||||
Children (0 – 17 years) | Referent | Referent | ||
Adults (18 – 64 years) | 0.090 | −0.018, 0.199 | 0.038 | −0.084, 0.160 |
Older adults (≥ 65 years) | 0.044 | −0.123, 0.211 | 0.046 | −0.132, 0.224 |
All ages/not reported | 0.108 | −0.004, 0.220 | 0.026 | −0.100, 0.152 |
GNI per capitab | 0.022 | 0.005, 0.039 | −0.024 | −0.041, −0.007 |
Source of infection | ||||
Hospital-associated | Referent | Referent | ||
Community-associated | −0.011 | −0.112, 0.091 | −0.315 | −0.413, −0.217 |
Hospital- or community-associated | 0.058 | −0.032, 0.148 | −0.100 | −0.183, −0.017 |
Livestock/animal associated | −0.128 | −0.341, 0.086 | −0.417 | −0.716, −0.119 |
Model characteristics | k=136, I2=99.84%, R2=10.86% | k=242, I2=99.47%, R2=21.47% |
The median or average of participants included in the study
World Bank data for country gross national income per capita in 201679